The EVO ICL (EVO Implantable Collamer Lens) is an FDA-approved implantable lens placed inside the eye to correct moderate to high nearsightedness, with or without astigmatism. Unlike LASIK, it does not reshape or remove any corneal tissue.
The EVO ICL is designed to be reversible and can be removed by an ophthalmologist if medically necessary. In addition, EVO ICL has a strong safety record in appropriately selected patients, making it a reassuring option for those considering surgical vision correction.
If you are tired of relying on glasses or contact lenses every day, you may be researching advanced vision correction options available in Orlando. LASIK is one of the best-known procedures, but it is not the only option for correcting nearsightedness. The EVO ICL is an implantable lens that can provide clear vision without irreversibly removing corneal tissue.
What’s Ahead
- What’s Ahead
- What Is the EVO ICL?
- How the EVO ICL Procedure Works
- Key Benefits of EVO ICL
- EVO ICL vs. LASIK: A Side-by-Side Comparison
- Who Is a Good Candidate for EVO ICL?
- What to Expect During EVO ICL Recovery
- What Are the Risks of EVO ICL?
- A Patient’s Perspective
- Frequently Asked Questions About EVO ICL
- Why Orlando Patients Consider EVO ICL
- Schedule Your Vision Consultation in Orlando
The FDA has approved the EVO ICL for appropriately selected patients. In 2026, the FDA expanded the approved age range for EVO and EVO Toric ICL lenses from 21 to 45 years old to 21 through 60 years old. In general, candidates should have stable prescriptions, healthy eyes, and meet certain anatomical requirements, such as adequate anterior chamber depth and sufficient endothelial cell count.
“It’s a total game changer for life.”
— EVO ICL patient, 6 months post-surgery, corrected from -12.00 D to 20/20 vision
This guide explains how the EVO ICL works, who may be a candidate, what the procedure involves, how recovery works, and how EVO ICL compares with LASIK.
What Is the EVO ICL?
The EVO ICL is an implantable Collamer lens used to correct nearsightedness (myopia), with or without astigmatism. It is a type of phakic intraocular lens, meaning the eye’s natural lens stays in place rather than being replaced.
The EVO ICL sits in the posterior chamber of the eye, behind the iris and in front of the natural crystalline lens. It works by changing how light is focused onto the retina, improving distance vision without removing corneal tissue.
The lens is made from Collamer, a biocompatible material that contains collagen and a polymer, and it includes built-in ultraviolet light protection.
The FDA approved the EVO ICL for appropriately selected patients with moderate to high myopia. The current FDA indication covers patients aged 21 to 60 years who meet specific prescribing, eye anatomy, and stability requirements.
One important distinction: the EVO ICL does not replace the eye’s natural lens. That sets it apart from procedures such as cataract surgery and refractive lens exchange.
For patients with higher levels of nearsightedness or corneas that may not be suitable for laser vision correction, an implantable lens can be an alternative worth discussing with an ophthalmologist.
How the EVO ICL Procedure Works
An ophthalmologist performs EVO ICL surgery, which is generally completed on an outpatient basis. According to the FDA patient information booklet, the procedure usually takes about 20 to 30 minutes.
The procedure generally involves five steps:
1. Eye preparation
The eye is prepared for surgery, and numbing medication is administered. Depending on the surgeon and patient, additional anesthesia or sedation may be discussed.
2. Small corneal incision
The surgeon creates a small incision in the clear front portion of the eye.
3. Lens insertion
The flexible EVO ICL is inserted through the incision and carefully positioned behind the iris and in front of the natural lens.
4. Lens positioning
The surgeon confirms that the lens is properly positioned within the eye.
5. Postoperative monitoring
After surgery, the surgeon monitors the eye, including intraocular pressure. The FDA patient information specifically recommends an eye pressure check within 1 to 6 hours after surgery, as a pressure spike may require prompt treatment.
The EVO ICL has a central port that allows fluid to move through the lens. This design eliminated the need for the peripheral iridotomy that older ICL models required.
Key Benefits of EVO ICL
EVO ICL may present several benefits for appropriately selected patients.
No removal of corneal tissue. LASIK changes the shape of the cornea by removing and reshaping corneal tissue. EVO ICL does not reshape or remove corneal tissue, which can make it an option for some patients with higher prescriptions or thinner corneas who may not be ideal LASIK candidates.
Designed for moderate to high myopia. The FDA indication for EVO ICL covers myopia from approximately minus 3.00 diopters through minus 20.00 diopters, depending on whether the goal is correction or reduction of myopia and whether astigmatism is present. Specific anatomical requirements also apply.
The natural lens remains in place. EVO ICL is a phakic lens, so the natural crystalline lens remains in place. This differs from refractive lens exchange, where the natural lens is removed.
Built-in UV protection. The EVO ICL material includes a UV-absorbing component. This is an added feature, but patients should still wear appropriate sunglasses outdoors.
It may help patients who do not qualify for LASIK. Patients told they are not good LASIK candidates because of corneal thickness, corneal shape, or a high degree of myopia may still qualify for EVO ICL, depending on a full eye examination.
Does not permanently reshape the cornea. Because no corneal tissue is removed, EVO ICL does not permanently reshape the cornea the way LASIK does. The lens is intended to remain in the eye long term, but can be removed by an ophthalmologist when medically appropriate. Removal does not guarantee the eye will return to its exact preoperative condition.
EVO ICL vs. LASIK: A Side-by-Side Comparison
| Factor | EVO ICL | LASIK |
|---|---|---|
| How it Works | An implantable lens is placed behind the iris and in front of the natural lens | A laser reshapes the cornea to change how light is focused |
| Corneal Tissue | No corneal tissue is removed | Corneal tissue is permanently reshaped |
| Natural Lens | Remains in place | Remains in place |
| Reversibility | Can be removed or exchanged by an ophthalmologist when medically necessary | Corneal reshaping is permanent |
| Dry Eye Considerations | No corneal flap or surface reshaping, which may appeal to patients concerned about dry eye | Dry eye is a recognized potential side effect; peer-reviewed research has documented changes to the ocular surface and corneal nerves after LASIK |
| Prescription Range | Suited for moderate to high myopia, including some very high prescriptions | Corrects a range of refractive errors, depending on prescription, corneal thickness, and shape |
| Vision Quality | Excellent outcomes possible in appropriately selected patients | Excellent outcomes possible in appropriately selected patients |
Neither procedure should be described as completely free of dry eye risk, and a patient’s existing ocular surface health should be evaluated before any vision correction procedure. The best procedure depends on prescription, corneal anatomy, ocular health, age, lifestyle, and visual goals, which is why a full evaluation from an ophthalmologist matters more than the name of the surgery.
Who Is a Good Candidate for EVO ICL?
The best way to determine candidacy is through a comprehensive eye examination and refractive surgery consultation.
A potential candidate generally needs to meet requirements that may include:
- Being within the FDA-approved age range of 21 through 60
- Having moderate to high nearsightedness within the approved prescription range
- Having a stable prescription for at least one year
- Having sufficient anterior chamber depth (at least 3.0 millimeters, per FDA patient information)
- Having an adequate endothelial cell count
- Having appropriate eye anatomy for the lens
- Having healthy eyes without certain conditions that could increase surgical risk
- Not being pregnant or nursing.
The American Academy of Ophthalmology also identifies factors to evaluate when considering phakic intraocular lenses, including anterior chamber depth, endothelial cell density, intraocular pressure, ocular health, and conditions such as glaucoma, cataracts, retinal disease, or active inflammation.
A high prescription or thin cornea does not automatically make someone a candidate for EVO ICL. The procedure still requires appropriate eye anatomy and overall ocular health.
What to Expect During EVO ICL Recovery
Recovery from EVO ICL surgery is usually quick, though the precise timeline varies from patient to patient.
Immediately after surgery: Vision may be noticeably clearer, though it may not be fully stable right away. Light sensitivity, mild irritation, or a sensation that something is in the eye are common during the first few days. Your surgeon will prescribe medications or eye drops as needed.
First day: A follow-up exam is typically performed the day after surgery to evaluate vision, eye pressure, and the overall condition of the eye.
First week: You will continue any prescribed medications and follow your surgeon’s restrictions on exercise, swimming, eye rubbing, and other activities.
In the following weeks, vision generally continues to stabilize as the eyes heal. Follow-up appointments let your ophthalmologist monitor eye pressure, lens position, and the health of your cornea and other eye structures.
Long-term monitoring remains important for patients with phakic intraocular lenses. We recommend ongoing eye exams because complications involving eye pressure, endothelial cells, inflammation, and cataract formation can develop over time.
What Are the Risks of EVO ICL?
EVO ICL is an intraocular surgical procedure, so it carries risks that should be discussed with an ophthalmologist before treatment. Serious complications from EVO ICL are rare, and most risks can be minimized and effectively managed with careful patient selection, proper surgical technique, and consistent follow-up care. Regular monitoring and prompt attention to any symptoms are key to detecting and addressing potential issues early.
Potential complications can include:
- Increased eye pressure
- Inflammation or infection
- Changes in the corneal endothelial cells
- Cataract formation
- Lens movement or displacement
- Glare or halos
- Residual refractive error
The EVO design has reduced some complications associated with earlier generations of phakic intraocular lenses, but no surgical procedure is completely risk-free. Proper patient selection, accurate lens sizing, surgical technique, and postoperative monitoring all result in a safe outcome.
A Patient’s Perspective
For patients with severe myopia, EVO ICL can be life-changing. One patient had worn glasses since infancy and reached a prescription of -12.00 diopters with several diopters of astigmatism, a level of myopia that made her ineligible for LASIK. Without correction, she couldn’t recognize a face at conversational distance and had to hold objects just inches from her eyes to bring them into focus.
After learning she was a candidate for EVO ICL, Chirag J. Patel, MD performed her surgery. In the recovery room, she saw her father’s face clearly for the first time she could remember. Six months later, her vision has stabilized at 20/20, with her prescription corrected from -12.00 D to essentially plano. As she put it, the procedure was “a total game changer for life.”
Frequently Asked Questions About EVO ICL
Why Orlando Patients Consider EVO ICL
Patients throughout Orlando and Central Florida have different needs when it comes to vision correction. Some have high prescriptions. Others have been told their corneas are not ideal for LASIK or have concerns about the effects of corneal laser surgery.
EVO ICL provides another option for appropriately selected patients. Rather than choosing a procedure based solely on its name, an ophthalmologist should evaluate prescription, corneal measurements, eye pressure, anterior chamber depth, endothelial cell count, comprehensive eye health, and visual goals.
Our team at Lake Nona Ophthalmology evaluates all of these factors to help patients understand whether EVO ICL, LASIK, another form of vision correction, or continued use of glasses and contacts is the right fit. Recommendations are tailored to each patient’s unique vision needs, eye anatomy, and personal goals, ensuring a supportive, individualized approach to vision correction.
Schedule Your Vision Consultation in Orlando
If you are considering EVO ICL in Orlando, the first step is a comprehensive consultation to determine whether you are a candidate.
We can evaluate your eyes, discuss your prescription and visual goals, and explain which vision correction options may be appropriate for you.
Medical and Patient Resources
For patients who want to learn more about EVO ICL from independent medical and regulatory sources, the following resources provide additional information:
U.S. Food and Drug Administration: The FDA provides information on the approval, indications, safety, and clinical data for EVO ICL. FDA information about EVO ICL
FDA Patient Information: The FDA-approved patient information booklet explains candidacy, the procedure, postoperative care, and possible risks. FDA EVO ICL Patient Information Booklet
American Academy of Ophthalmology: EyeWiki provides information about phakic intraocular lenses, including patient selection, surgical considerations, outcomes, and potential complications. American Academy of Ophthalmology EyeWiki: Phakic Intraocular Lenses
Peer-Reviewed Research: PubMed provides access to published research on the safety and effectiveness of EVO ICL and other vision correction procedures. PubMed: EVO ICL Research
This article is for educational purposes and does not replace an individualized medical evaluation. Candidacy for EVO ICL can only be determined through a comprehensive eye exam with a qualified ophthalmologist. If you are interested in learning whether EVO ICL is the right option for you, we invite you to schedule a consultation. Booking a visit is the best way to receive a personalized assessment and clear guidance on your vision correction options.
